kwic
under
under
right
off
ON
150
1
100
500
strict
ELIZA cgi-bash version rev. 1.90
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for under out of >500 occurrences
321496 occurrences (No.66 in the rank) during 5 years in the PubMed. [no cache] 500 found
--- ABSTRACT ---
--- ABSTRACT END ---
[frequency of next (right) word to under]
321496 occurrences (No.66 in the rank) during 5 years in the PubMed. [no cache] 500 found
| 150) Since its limited dietary uptake and decrease in its endogenous synthesis in the body with age and under various diseases states warrants its adequate supply from an external source. |
| PMID:24090245 DOI:10.3109/07388551.2013.823594 |
| 2015 Critical reviews in biotechnology |
| * Coenzyme Q10 production in plants: current status and future prospects. |
| - Coenzyme Q10 (CoQ10) or Ubiquinone10 (UQ10), an isoprenylated benzoquinone, is well-known for its role as an electron carrier in aerobic respiration. It is a sole representative of lipid soluble antioxidant that is synthesized in our body. In recent years, it has been found to be associated with a range of patho-physiological conditions and its oral administration has also reported to be of therapeutic value in a wide spectrum of chronic diseases. Additionally, as an antioxidant, it has been widely used as an ingredient in dietary supplements, neutraceuticals, and functional foods as well as in anti-aging creams. Since its limited dietary uptake and decrease in its endogenous synthesis in the body with age and under various diseases states warrants its adequate supply from an external source. To meet its growing demand for pharmaceutical, cosmetic and food industries, there is a great interest in the commercial production of CoQ10. Various synthetic and fermentation of microbial natural producers and their mutated strains have been developed for its commercial production. Although, microbial production is the major industrial source of CoQ10 but due to low yield and high production cost, other cost-effective and alternative sources need to be explored. Plants, being photosynthetic, producing high biomass and the engineering of pathways for producing CoQ10 directly in food crops will eliminate the additional step for purification and thus could be used as an ideal and cost-effective alternative to chemical synthesis and microbial production of CoQ10. A better understanding of CoQ10 biosynthetic enzymes and their regulation in model systems like E. coli and yeast has led to the use of metabolic engineering to enhance CoQ10 production not only in microbes but also in plants. The plant-based CoQ10 production has emerged as a cost-effective and environment-friendly approach capable of supplying CoQ10 in ample amounts. The current strategies, progress and constraints of CoQ10 production in plants are discussed in this review. |
[
right
kwic]
(1)95  the |
(18)4 these |
(35)2 axial |
(52)2 of |
| (2)13 different |
(19)3 high |
(36)2 censoring |
(53)2 optimal |
| (3)12 a |
(20)3 investigation |
(37)2 clinical |
(54)2 physiological |
| (4)9 general |
(21)3 light |
(38)2 consideration |
(55)2 pulsatile |
| (5)8 both |
(22)3 local |
(39)2 controlled |
(56)2 scanning |
| (6)8 which |
(23)3 mechanical |
(40)2 current |
(57)2 serum-free |
| (7)7 various |
(24)2 *null* | (41)2 evaluation |
(58)2 several |
| (8)6 conditions |
(25)2 12 |
(42)2 ex |
(59)2 simulated |
| (9)6 curve |
(26)2 15 |
(43)2 extreme |
(60)2 specific |
| (10)6 static |
(27)2 2 |
(44)2 four |
(61)2 steady-state |
| (11)5 and |
(28)2 CA |
(45)2 hypertensive |
(62)2 therapy |
| (12)4 5 |
(29)2 CT |
(46)2 hypoxia |
(63)2 this |
| (13)4 certain |
(30)2 H2O2-induced |
(47)2 hypoxic |
(64)2 time |
| (14)4 control |
(31)2 UV |
(48)2 inflammatory |
(65)2 treatment |
| (15)4 either |
(32)2 acute |
(49)2 laser |
(66)2 ultrasound |
| (16)4 in |
(33)2 additive |
(50)2 lateral |
(67)2 vertical |
| (17)4 normal |
(34)2 adverse |
(51)2 mortality |
(68)2 water |
add keyword
--- WordNet output for under ---